{"nctId":"NCT00089843","briefTitle":"Bone Loss in Women With Anorexia Nervosa","startDateStruct":{"date":"2003-06"},"conditions":["Anorexia Nervosa"],"count":77,"armGroups":[{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Testosterone","Drug: Placebo Actonel (risedronate)"]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Testosterone","Drug: Actonel (risedronate)"]},{"label":"4","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Actonel (risedronate)","Drug: Placebo testosterone"]},{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Actonel (risedronate)","Drug: Placebo testosterone"]}],"interventions":[{"name":"Testosterone","otherNames":["Intrinsa"]},{"name":"Actonel (risedronate)","otherNames":["Actonel"]},{"name":"Placebo Actonel (risedronate)","otherNames":[]},{"name":"Placebo testosterone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Anorexia Nervosa,\n* Over 18,\n* Female,\n* Decreased bone density\n\nExclusion Criteria:\n\n* Medications to increase bone density","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Bone Mineral Density","description":"Percent change in postero-anterior (PA) spine bone mineral density as measured by dual energy x-ray absorptiometry (DXA)over a 12-month period. The differences in log-transformed values are reported as percent change.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":null},{"groupId":"OG001","value":"-0.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Markers of Bone Metabolism","description":"type 1 collagen C-telopeptide(CTX); The differences in log-transformed values are reported as percent change.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-41","spread":null},{"groupId":"OG001","value":"-11","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":19},"commonTop":["Mild increase in acne or oily skin","Mild irritation at patch site","Mild increase in body hair growth","Reflux","Myalgias"]}}}